WEBULL
News
OSRHW
0.0510
0.00%
0.0000
Woori IO Shareholders Approve Share Exchange with OSR Holdings
Reuters · 12/19/2025 16:50
WOORI IO SHAREHOLDERS APPROVE SHARE EXCHANGE TO BECOME WHOLLY-OWNED SUBSIDIARY OF OSR HOLDINGS
Reuters · 12/19/2025 16:50
Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target
Reuters · 12/04/2025 20:19
BRIEF-OSR Holdings Says Vaximm AG Shortens Exclusivity Period With BCM Europe To Three Months
Reuters · 12/02/2025 18:22
OSR HOLDINGS INC - VAXIMM AG SHORTENS EXCLUSIVITY PERIOD WITH BCM EUROPE TO THREE MONTHS
Reuters · 12/02/2025 14:55
Vaximm AG Shortens Exclusivity Period With BCM Europe for Cancer Immunotherapy Deal
Reuters · 12/02/2025 14:54
OSR Holdings to Present Corporate Overview at Emerging Growth Conference
Reuters · 12/01/2025 20:02
Vaximm AG Enters $835M License Term Sheet With BCM Europe for Cancer Immunotherapy
Reuters · 11/25/2025 15:56
OSR Holdings Reports High Accuracy for Woori IO Noninvasive Glucose Monitor in Pilot Study
Reuters · 11/25/2025 06:43
Vaximm AG Enters $20M Term Sheet for VXM01 License Negotiations
Reuters · 11/21/2025 14:20
Vaximm AG Names Scientific Co-Founder Andreas Niethammer as CEO
Reuters · 11/14/2025 16:11
OSR HOLDINGS APPOINTS SCIENTIFIC CO-FOUNDER DR. ANDREAS NIETHAMMER AS CHIEF EXECUTIVE OFFICER OF VAXIMM AG TO LEAD NEXT PHASE OF IMMUNO-ONCOLOGY EXPANSION
Reuters · 11/14/2025 16:11
OSR Holdings Reports High Accuracy in Woori IO Noninvasive Glucose Monitor Pilot Study
Reuters · 11/06/2025 13:31
OSR HOLDINGS ANNOUNCES WOORI IO'S NONINVASIVE GLUCOSE MONITOR DEMONSTRATES HIGH ACCURACY AND PRECISION IN COMPANY-SPONSORED PILOT STUDY
Reuters · 11/06/2025 13:30
OSR Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Reto Kaspar Fierz
Reuters · 10/24/2025 16:58
Emerging Growth Research Initiates Buy Rating on OSR Holdings with $10 Price Target
Reuters · 10/20/2025 15:40
OSR Holdings to Acquire Woori IO, Advancing Noninvasive Glucose Monitoring Technology
Reuters · 10/16/2025 15:11
OSR Holdings to Acquire Woori IO, Advancing Noninvasive Glucose Monitoring Technology
Reuters · 10/14/2025 12:31
OSR HOLDINGS INC - WORIO SHAREHOLDERS TO RECEIVE OSRK SHARES WORTH $10.5 MLN
Reuters · 10/14/2025 12:31
OSR Holdings Inc. Held Annual Stockholders Meeting
Reuters · 09/23/2025 15:27
More
Webull provides a variety of real-time OSRHW stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRHW
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.